The most commonly prescribed GLP1 injectable medications in Australia include: Tirzepatide (brand name: Mounjaro KwikPen), which is a dual GIP/GLP1 receptor agonist supplied as a multi-dose pre-filled pen containing four weekly doses per pen
PMI and PTK hydrogels (10 mg/mL) were incubated with defined serum-free chondrogenic medium for 12 h, which was used to co-culture with the pellets for 21 days
We and others have shown that islet GLP-1 is increased during conditions of islet-stress 2,4,14,15,32 , likely through increased pro-glucagon transcription and PC1/3 expression 9
Microdosing would mean injecting any amount lower than that minimal dose, whether thats 1, 1.5 or 2.3 mg
The easiest way to get exposure to this trend is with LLY and NVO, as their duopoly will maintain until at least 2027
Follow your SOP and the SDS for stability, container choice, and holding time